A novel coronavirus phosphate, a novel coronavirus pneumonia drug, has a fatal risk.

Novel coronavirus pneumonia recovery period guidance for Chinese medicine rehabilitation was issued and trial launched; the former Blanchard of Lilai took over Everest CEO; 10 new crown virus detection kit had been approved; the new immune cells were helpful for tumor immunotherapy.. Everest Daily fresh medicine news, speed reading club and you pay attention to! As of 24:00 on February 23, according to the reports of 31 provinces (autonomous regions, municipalities directly under the central government) and Xinjiang production and Construction Corps, there are 49824 confirmed cases, 24734 cured and discharged cases, 2592 dead cases, 77150 confirmed cases and 3434 suspected cases (official website of national health and Health Commission) Novel coronavirus novel coronavirus pneumonia novel coronavirus pneumonia novel coronavirus pneumonia recovery period rehabilitation, in summing up the new crown pneumonia TCM rehabilitation experience, the State Council should respond to the new coronavirus pneumonia epidemic prevention and control mechanism medical treatment group organization experts formulated the "new coronavirus pneumonia recovery period of Chinese medicine rehabilitation guidance advice (Trial)" (State Administration of traditional Chinese Medicine) Recently, the national health and Health Commission issued a document that areas outside Hubei Province should closely integrate the situation of epidemic development, focus on epidemic prevention and control and medical services at the same time, instead of one size fits all, stop diagnosis and shut down daily medical services (National Health and Health Commission) Novel coronavirus pneumonia novel coronavirus pneumonia has been adjusted to the level of emergency response in the country As of 12:00 p.m on the 24th, six provinces had adjusted their emergency response levels In Guangdong and Shanxi, the first level response to major public health emergencies was adjusted to the second level response, while in Gansu, Liaoning, Guizhou and Yunnan, the first level response was adjusted to the third level response (CCTV) Recently, Dr Kerry L Blanchard, former director of China's drug development department of Lilly, will take the post of CEO of Everest medicine, and Blanchard will join Everest medicine as a working partner of Kangqiao capital （GBIHealth） On April 24, Hengrui released a notice that shr5126 tablets were approved for clinical use and were intended to be used for the treatment of solid patients, with specific indications to be determined in clinical trials (enterprise announcement) 22, novel coronavirus products were detected in 3 enterprises by 3 new coronavirus products, including 2 colloidal gold antibody detection reagents and 1 isothermal amplification chip nucleic acid detection reagents, the State Drug Administration said Up to now, a total of 10 new coronavirus detection kits have been approved for marketing through the "emergency channel" (SFDA) 22, a novel coronavirus registered for the safety and efficacy of new coronavirus pneumonia in severe and critically ill patients was donated by the biotech Limited by Share Ltd (Insight database) Hunan Mingrui Pharmaceutical Co., Ltd has issued approval documents for the listing application of six generic Lanthanum Carbonate Chewable Tablets Monday, which is expected to be approved If approved, Mingrui pharmaceutical will be the first enterprise in China to win the first imitation of lanthanum carbonate (CPHI Pharma online) Recently, nono Inc announced the positive results of a key phase III clinical trial, escape-na1: patients who have experienced acute ischemic stroke after intravascular thrombectomy do not need to take articipase in advance, and the intravenous infusion of nerinetide has brought important treatment improvements to the patients (Sina Medical News) Recently, Hubei Provincial Health and Health Commission issued the notice on close observation of adverse reactions of chloroquine phosphate to the health and health committees of cities, prefectures, municipalities directly under the administration of Hubei Province and medical institutions under the Ministry and province China's novel coronavirus pneumonia was recommended for the treatment of new crown pneumonia, "according to the circular," the 2-4G dose of the drug in adults is also acute death according to the Wuhan Institute of Chinese Academy of Sciences (Hubei Provincial Health and Health Commission) Recently, researchers have found a new mechanism related to Down's syndrome The team focused on RCAN1, which is overexpressed in the brains of Down's fetuses The team's work provides insight into how genes affect the way diseases behave The findings were published in current biology (Biovalley)